Erik Knudsen and Agnieszka Witkiewicz, UT Southwestern Medical Center (IMAGE)
Caption
A genetic analysis led by Dr. Erik Knudsen (left) and Dr. Agnieszka Witkiewicz suggests that most pancreatic cancers harbor genetic alterations that could be targeted by existing drugs, using their genetic features as a roadmap for treatment.
Credit
UT Southwestern Medical Center
Usage Restrictions
With source credit
License
Licensed content